Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4–5 Years After a Primary 3-Dose Schedule
暂无分享,去创建一个
N. Jackson | R. Dietze | J. Arredondo-García | B. Zambrano | F. Noriega | M. Cortés | M. Bonaparte | E. García-Rivera | Maribel Rivera | A. P. Perroud | D. Coronel | Mihaela Tila | Jessie Zhao
[1] T. Westling,et al. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy , 2018, The New England journal of medicine.
[2] Lindsay N. Carpp,et al. Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America , 2018, The Journal of infectious diseases.
[3] Dengue vaccine: WHO position paper, September 2018 - Recommendations. , 2018, Vaccine.
[4] B. Guy,et al. Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination , 2017, Human vaccines & immunotherapeutics.
[5] H. Margolis,et al. Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians. , 2016, Journal of travel medicine.
[6] G. Carrasquilla,et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.
[7] P. Pitisuttithum,et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.
[8] R. Dietze,et al. Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil , 2013, The American journal of tropical medicine and hygiene.
[9] M. Boaz,et al. Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds: A Randomized, Controlled, Phase II Trial in Latin America , 2013, The Pediatric infectious disease journal.
[10] T. Timiryasova,et al. Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development , 2013, The American journal of tropical medicine and hygiene.
[11] P. Gething,et al. Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus , 2012, PLoS neglected tropical diseases.